Literature DB >> 24777614

Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APC(Min/+) mice.

Paulina Akeus1, Veronica Langenes, Astrid von Mentzer, Ulf Yrlid, Åsa Sjöling, Pushpa Saksena, Sukanya Raghavan, Marianne Quiding-Järbrink.   

Abstract

Tumor progression in the colon moves from aberrant crypt foci to adenomatous polyps to invasive carcinomas. The composition of the tumor-infiltrating leukocyte population affects the ability of the immune system to fight the tumor. T cell infiltration into colorectal adenocarcinomas, particularly T helper 1 (Th1) type T cells as well as increased regulatory T cell (Treg) frequencies, is correlated with improved prognosis. However, whether Th1 cells and Tregs are already present at the adenoma stage is not known. In this study, the APC(Min/+) mouse model of intestinal adenomatous polyposis was used to investigate tumor-associated lymphocyte subsets and the mechanisms of their accumulation into gastrointestinal adenomas. Compared to unaffected tissue, adenomas accumulated CD4(+)FoxP3(+) putative Treg in parallel with lower frequencies of conventional T cells and B cells. The accumulation of Treg was also observed in human adenomatous polyps. Despite high Treg numbers, the function of conventional T cells present in the APC(Min/+) adenomas was not different from those in the unaffected tissue. Adenomas displayed an altered chemokine balance, with higher CCL17 and lower CXCL11 and CCL25 expression than in the unaffected tissue. In parallel, CXCR3(+) Tregs were largely absent from adenomas. The data indicate that already in early stages of tumor development, the balance of lymphocyte-recruiting chemokines is altered possibly contributing to the observed shift toward higher frequencies of Treg.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24777614     DOI: 10.1007/s00262-014-1555-6

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  11 in total

Review 1.  Evolving notions on immune response in colorectal cancer and their implications for biomarker development.

Authors:  Fabio Grizzi; Gianluca Basso; Elena Monica Borroni; Tommaso Cavalleri; Paolo Bianchi; Sanja Stifter; Maurizio Chiriva-Internati; Alberto Malesci; Luigi Laghi
Journal:  Inflamm Res       Date:  2018-01-10       Impact factor: 4.575

2.  De novo assembly provides new insights into the evolution of Elaeagnus angustifolia L.

Authors:  Yunfei Mao; Xueli Cui; Haiyan Wang; Xin Qin; Yangbo Liu; Yijun Yin; Xiafei Su; Juan Tang; Fengling Wang; Fengwang Ma; Naibin Duan; Donglin Zhang; Yanli Hu; Wenli Wang; Shaochong Wei; Xiaoliu Chen; Zhiquan Mao; Xuesen Chen; Xiang Shen
Journal:  Plant Methods       Date:  2022-06-18       Impact factor: 5.827

3.  Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APCMin/+ mice.

Authors:  Louis Szeponik; Paulina Akeus; William Rodin; Sukanya Raghavan; Marianne Quiding-Järbrink
Journal:  Cancer Immunol Immunother       Date:  2020-03-17       Impact factor: 6.968

4.  Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.

Authors:  Manabu Takamatsu; Akihiro Hirata; Hirofumi Ohtaki; Masato Hoshi; Tatsuya Ando; Hiroyasu Ito; Yuichiro Hatano; Hiroyuki Tomita; Toshiya Kuno; Kuniaki Saito; Mitsuru Seishima; Akira Hara
Journal:  Cancer Sci       Date:  2015-07-14       Impact factor: 6.716

5.  Chronic Trichuris muris infection causes neoplastic change in the intestine and exacerbates tumour formation in APC min/+ mice.

Authors:  Kelly S Hayes; Laura J Cliffe; Alison J Bancroft; Simon P Forman; Seona Thompson; Cath Booth; Richard K Grencis
Journal:  PLoS Negl Trop Dis       Date:  2017-06-26

Review 6.  Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.

Authors:  Elizabeth A Comen; Robert L Bowman; Maria Kleppe
Journal:  Front Cell Dev Biol       Date:  2018-06-12

7.  Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APCmin/+ mice.

Authors:  Paulina Akeus; Louis Szeponik; Filip Ahlmanner; Patrik Sundström; Samuel Alsén; Bengt Gustavsson; Tim Sparwasser; Sukanya Raghavan; Marianne Quiding-Järbrink
Journal:  Cancer Immunol Immunother       Date:  2018-04-18       Impact factor: 6.968

8.  Increased Incidence of Colon Tumors in AOM-Treated Apc 1638N/+ Mice Reveals Higher Frequency of Tumor Associated Neutrophils in Colon Than Small Intestine.

Authors:  Rebecca Metzger; Mahulena Maruskova; Sabrina Krebs; Klaus-Peter Janssen; Anne B Krug
Journal:  Front Oncol       Date:  2019-10-02       Impact factor: 6.244

Review 9.  Colorectal cancer prevention: Immune modulation taking the stage.

Authors:  Rochelle Fletcher; Yi-Jun Wang; Robert E Schoen; Olivera J Finn; Jian Yu; Lin Zhang
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-01-31       Impact factor: 11.414

10.  YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation.

Authors:  Hua Sui; Lu Zhang; Kaijuan Gu; Ni Chai; Qing Ji; Lihong Zhou; Yan Wang; Junze Ren; Limei Yang; Bimeng Zhang; Jing Hu; Qi Li
Journal:  Cell Commun Signal       Date:  2020-07-16       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.